Ironwood Pharmaceuticals | IRWD - Ebit





Ebit Veränderung Datum
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 71.55M 41.32M 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amarin USD -2.26M 564K 2025-12
Ardelyx USD -10.39M 20.29M 2026-06
Astellas Pharma JPY 132.59B 52.76B 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Charles River Laboratories USD 221.85M 101.96M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -65.25M 33.36M 2026-06
Moderna USD 130M 945M 2026-09
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 2.57B 2.56B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Takeda JPY 205.32B 3.9B 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12